1. Home
  2. SGMA vs TNXP Comparison

SGMA vs TNXP Comparison

Compare SGMA & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMA
  • TNXP
  • Stock Information
  • Founded
  • SGMA 1993
  • TNXP 2007
  • Country
  • SGMA United States
  • TNXP United States
  • Employees
  • SGMA N/A
  • TNXP N/A
  • Industry
  • SGMA Electrical Products
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • SGMA Technology
  • TNXP Health Care
  • Exchange
  • SGMA Nasdaq
  • TNXP Nasdaq
  • Market Cap
  • SGMA 16.1M
  • TNXP 15.1M
  • IPO Year
  • SGMA 1994
  • TNXP N/A
  • Fundamental
  • Price
  • SGMA $3.03
  • TNXP $0.14
  • Analyst Decision
  • SGMA
  • TNXP Strong Buy
  • Analyst Count
  • SGMA 0
  • TNXP 2
  • Target Price
  • SGMA N/A
  • TNXP $53.50
  • AVG Volume (30 Days)
  • SGMA 33.9K
  • TNXP 35.7M
  • Earning Date
  • SGMA 09-19-2024
  • TNXP 11-07-2024
  • Dividend Yield
  • SGMA N/A
  • TNXP N/A
  • EPS Growth
  • SGMA N/A
  • TNXP N/A
  • EPS
  • SGMA N/A
  • TNXP N/A
  • Revenue
  • SGMA $360,530,443.00
  • TNXP $12,458,000.00
  • Revenue This Year
  • SGMA N/A
  • TNXP $62.53
  • Revenue Next Year
  • SGMA N/A
  • TNXP $26.17
  • P/E Ratio
  • SGMA N/A
  • TNXP N/A
  • Revenue Growth
  • SGMA N/A
  • TNXP N/A
  • 52 Week Low
  • SGMA $2.27
  • TNXP $0.12
  • 52 Week High
  • SGMA $6.47
  • TNXP $22.08
  • Technical
  • Relative Strength Index (RSI)
  • SGMA 54.40
  • TNXP 29.54
  • Support Level
  • SGMA $2.83
  • TNXP $0.12
  • Resistance Level
  • SGMA $3.20
  • TNXP $0.21
  • Average True Range (ATR)
  • SGMA 0.18
  • TNXP 0.02
  • MACD
  • SGMA 0.09
  • TNXP 0.02
  • Stochastic Oscillator
  • SGMA 71.87
  • TNXP 21.56

About SGMA SigmaTron International Inc.

Sigmatron International Inc is an independent provider of electronic manufacturing services (EMS). It provides manufacturing and assembly services ranging from the assembly of individual components to the assembly and testing of box-build electronic products. The company manufactures products like printed circuit board assemblies, electro-mechanical subassemblies, and completely assembled (box-build) electronic products which are incorporated into finished products and sold in various industries, particularly industrial electronics, consumer electronics, and life sciences. In some instances, it manufactures and assembles the completed finished product for its customers. Geographically, the company derives maximum revenue from Mexico and the rest from the United States, China, and Vietnam.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: